Blood Transcriptome Profiling in Myasthenia Gravis Patients to Assess Disease Activity: A Pilot RNA-seq Study

Myasthenia gravis (MG) is an antibody-mediated autoimmune disease characterized by exertional weakness. There is no biomarker to reflect disease activity and guide treatment decision. Here, we reported a pilot blood transcriptome study using RNA sequencing (RNA-seq) that identified differences of 5...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Kee Hong, Jung, Junghee, Lee, Jung-Hee, Hong, Yoon-Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Brain and Neural Science 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766113/
https://www.ncbi.nlm.nih.gov/pubmed/26924932
http://dx.doi.org/10.5607/en.2016.25.1.40

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766113/
https://www.ncbi.nlm.nih.gov/pubmed/26924932
http://dx.doi.org/10.5607/en.2016.25.1.40

Ejemplares similares